Recent Posts
- Biotech TV Podcast: George Church on founder-led companies, synthetic biology, the future of biotechnology, and more
- Endpoints News: George Church Spinout Raises $60M for Protein Therapies from Genomically Recoded Organisms
- Biotech TV: GRO Biosciences Announced a $60 Million Series B Today to Help Advance its Pipeline that is Rooted in Adding Non-Standard Amino Acid (NSAA) Chemistries to Therapies
- Fierce Biotech: GRObio Gathers $60M Series B to Take Gout Rival to Krystexxa into Clinic
- Boston Business Journal: George Church Spinout to Enter Clinic with New $60M Investment
Archives
- October 2024
- July 2024
- April 2024
- March 2024
- October 2023
- September 2023
- July 2023
- April 2023
- December 2022
- September 2022
- February 2022
- January 2022
- December 2021
- November 2021
- July 2021
- December 2020
- September 2020
- December 2019
- November 2019
- September 2019
- June 2018
- May 2018
- September 2017
- September 2016
- August 2016
- May 2016
- December 2015
- February 2015
- January 2015
- January 2014
- October 2013